Do you want to read an article? Please log in or register.
Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome
Further Publications
Related content
COMMENTED
Diabetes and Pregnancy
Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial
Lancet Diabetes Endocrinol.
Løvvik TS, Carlsen SM, Salvesen Ø, Steffensen B, Bixo M, Gómez-Real F, Lønnebotn M, Hestvold KV, Zabielska R, Hirschberg AL, Trouva A, Thorarinsdottir S, Hjelle S, Berg AH, Andræ F, Poromaa IS, Mohlin J, Underdal M, Vanky E
doi: 10.1016/S2213-8587(19)30002-6.
COMMENTED
Type 2 Diabetes
Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials
BMJ.
Brown TJ, Brainard J, Song F, Wang X, Abdelhamid A, Hooper L, PUFAH Group.
doi: 10.1136/bmj.l4697.
Obesity and Bariatric Surgery
Comparison of Smartphone-Based Behavioral Obesity Treatment With Gold Standard Group Treatment and Control: A Randomized Trial
Obesity (Silver Spring).
Thomas JG, Bond DS, Raynor HA, Papandonatos GD, Wing RR
doi: 10.1002/oby.22410.
Type 2 Diabetes
The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome
Diabetes Care.
Kakoly NS, Earnest A, Teede HJ, Moran LJ, Joham AE
doi: 10.2337/dc18-1738.
COMMENTED
Diabetes - GeneralGlycemic Control
Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care.
Christensen AS, Hædersdal S, Støy J, Storgaard H, Kampmann U, Forman JL, Seghieri M, Holst JJ, Hansen T, Knop FK, Vilsbøll T
doi: 10.2337/dc20-0408.
Glycemic Control
Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: results of a phase 3, randomized controlled trial
Pediatr Diabetes
Battelino T, Tehranchi R, Bailey T, Dovc K, Melgaard A, Stone JY, Woerner S, Berge TVD, DiMeglio LA, Danne T
doi: 10.1111/pedi.13220
Type 2 Diabetes
Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial
Diabetes Obes Metab
Weng J, Zeng L, Zhang Y, Qu S, Wang X, Li P, Fu L, Ma B, Ye S, Sun J, Lu W, Liu Z, Chen D, Cheng Z, Liu H, Zhang T, Zou J
doi: 10.1111/dom.14389
Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery
Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome
J Clin Endocrinol Metab.
Rubin KH, Glintborg D, Nybo M, Abrahamsen B, Andersen M
doi: 10.1210/jc.2017-01354.
Further Publications
Henagliflozin Monotherapy in Patients with Type 2 Diabetes Inadequately Controlled on Diet and Exercise: A Randomized, Double-blind, Placebo-controlled, Phase 3 Trial
Diabetes Obes Metab
Lu J, Fu L, Li Y, Geng J, Qin L, Ping L, Zheng H, Sun Z, Li Y, Zhang L, Sun Y, Chen D, Qin G, Weiping L, Guo Y, Zhang Y, Liu H, Zhang T, Zou J
doi: 10.1111/dom.14314